- $0.45m
- $0.45m
- $2.55m
Brief: NanoVibronix Provides Update On Expanding Access To PainShield
Brief: NanoVibronix Announces Partnership With Peak Medical
U.S. STOCKS ON THE MOVE-Apple Inc, Expensify Inc, Nexstar Media Group
U.S. STOCKS ON THE MOVE-Novavax, Cerence, Hibbett
U.S. STOCKS ON THE MOVE-Citi Trends, ConocoPhillips, ASP Isotopes
NanoVibronix falls on direct stock deal
Brief: Nanovibronix Announces $2.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Nanovibronix Receives FDA 510(K) Premarket Clearance For Painshield Plus
Brief: Nanovibronix Announces Interim Results Of Clinical Study For Uroshield
Brief: Nanovibronix Provides Business Update In Letter To Shareholders
Brief: Nanovibronix Receives Extension To Satisfy Nasdaq Price Requirement
NanoVibronix jumps on new contract with U.K.'s NHS for UroShield device
Brief: Nanovibronix Uroshield Approved For Sale Through NHS Internal Supply Chain Contract
Brief: NanoVibronix Announces Receipt Of Nasdaq Listing Determination Company To Request Hearing
Brief: Nanovibronix Says Shifting Majority Of Manufacturing Operations To Singapore To Allow Scalability Increase Efficiency, Address Potential Supply Chain Delays
Brief: NanoVibronix Reports First Quarter 2022 Financial Results
NanoVibronix rises on FDA filing for next-generation pain management device
Brief: Nanovibronix Announces FDA 510(K) Submission For Painshield MD Plus
U.S. STOCKS ON THE MOVE-Inspirato Inc, PVH Corp, Whirlpool Corp